Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 0.0 | BCD100427B02 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 0.5 | BCD100427B05 | 1.2 | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 1.0 | BCD100427B09 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 2.0 | BCD100427B13 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 4.0 | BCD100427B17 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 8.0 | BCD100427B21 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 12.0 | BCD100427B25 | - | pmol/sample |
LMST01020025 | CE(22:1) | Lipid-depleted/compactin | 24.0 | BCD100427B29 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 0.0 | BCD100427B01 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 0.5 | BCD100427B03 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 1.0 | BCD100427B07 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 2.0 | BCD100427B11 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 4.0 | BCD100427B15 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 8.0 | BCD100427B19 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 12.0 | BCD100427B23 | - | pmol/sample |
LMST01020025 | CE(22:1) | C | 24.0 | BCD100427B27 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B06 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B10 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B14 | 1.33 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B18 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B22 | 2.39 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B26 | 5.6 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B30 | 7.42 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 0.5 | BCD100427B04 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 1.0 | BCD100427B08 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 2.0 | BCD100427B12 | - | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 4.0 | BCD100427B16 | 4.18 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 8.0 | BCD100427B20 | 2.7 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 12.0 | BCD100427B24 | 2.46 | pmol/sample |
LMST01020025 | CE(22:1) | 25OH-Chol | 24.0 | BCD100427B28 | 3.54 | pmol/sample |